The application of neurosciences in the treatment of patients with Spinocerebellar Ataxia type II (SCA2) stands out among the main results of the Center for Research and Rehabilitation dedicated to this pathology in the province of Holguin.
Dr. Roberto Rodríguez, specialist of the institution, the only one of its kind in Cuba, told the ACN that the studies of this discipline are oriented towards clinical and molecular investigations.
He highlighted among the most notable results, the development of effective rehabilitation therapies in pre-clinical carriers of the disease.
Rodríguez added that neurosciences have also allowed the identification of clinical, electrophysiological and imaging biomarkers, which allow defining the behavior of the pathology from early onset stages.
These studies have a positive effect in the quality of life of patients, as they allow checking the effect of drugs or rehabilitation and evaluating the genetic changes that occurred in the process.
The SCA2 is a hereditary and progressive disease, whose appearance varies from two to 65 years of age and the province of Holguin registers 80 percent of the existing cases in Cuba.
The Center for Research and Rehabilitation of Hereditary Ataxias (CIRAH), founded in 2002, develops researches for the treatment of the pathology, which has among its main symptoms the difficulties of swallowing, speaking, instability of eye movements and loss of balance.